Lansdowne Partners Austria Gmbh insider trades: Alexza Pharmaceuticals (ALXA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lansdowne Partners Austria Gmbh reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 18, 2013 | ALXA | ↓ Sell | 25,000 | $4.75 | $119K | Indirect | Jan 22, 2013 (4d) |
| Jan 17, 2013 | ALXA | ↓ Sell | 100,000 | $4.75 | $475K | Indirect | Jan 22, 2013 (5d) |
| Dec 27, 2012 | ALXA | ↑ Buy | 72,189 | $4.85 | $350K | Indirect | Dec 31, 2012 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lansdowne Partners Austria Gmbh's insider trades
Lansdowne Partners Austria Gmbh is a 10% owner of Alexza Pharmaceuticals (ALXA). Since Dec 27, 2012, it has reported 1 open-market purchase worth $350K and 2 sales worth $594K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALXA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.